Stay informed with the latest litigation news. Explore now

Yeda Research competitive analysis

Latest publications and patents of Yeda Research New

Explore the latest publications and patents granted to Yeda Research, showcasing their recent innovations and technological advancements.

Last updated on: Sep 8, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Yeda Research

Aug 13, 2025Stress Management In Human Subjects In Need ThereofGranted And Under Opposition
Jan 18, 2023System And Method For Orientating Capture Of Ultrasound ImagesGranted And Under Opposition
Nov 2, 2022Immunotherapy Using Redirected Allogeneic CellsPatent Maintained As Amended
Jul 27, 2022Redirected, Genetically-Engineered T Regulatory Cells And Their Use In Suppression Of Autoimmune And Inflammatory DiseaseGranted And Under Opposition
Aug 12, 2020Low Frequency Glatiramer Acetate TherapyRevoked
Jul 11, 2018Dosing Regimen For Multiple SclerosisRevoked
Jun 27, 2018Low Frequency Glatiramer Acetate TherapyRevoked
Apr 25, 2018Process And Apparatus For Producing Inorganic Fullerene-Like NanoparticlesNo Opposition Filed Within Time Limit
Jan 17, 2018Nuclear Targeting SequencesNo Opposition Filed Within Time Limit
Jan 17, 2018Combinations Of Anti Erbb Antibodies For The Treatment Of CancerNo Opposition Filed Within Time Limit

Explore Yeda Research's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jan 18, 2023System And Method For Orientating Capture Of Ultrasound Images1
Nov 2, 2022Immunotherapy Using Redirected Allogeneic Cells1
Jul 27, 2022Redirected, Genetically-Engineered T Regulatory Cells And Their Use In Suppression Of Autoimmune And Inflammatory Disease1
Aug 12, 2020Low Frequency Glatiramer Acetate Therapy2
Jul 11, 2018Dosing Regimen For Multiple Sclerosis5
Jun 27, 2018Low Frequency Glatiramer Acetate Therapy5
Jan 4, 2017Low Frequency Glatiramer Acetate Therapy6

Latest PTAB cases involving Yeda Research New

Discover the latest PTAB cases involving Yeda Research, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Yeda Research

IPR2017-00195Nov 2, 2016MYLAN PHARMACEUTICALSYEDA RESEARCHTerminated
PGR2016-00028Jul 12, 2016AMNEAL PHARMACEUTICALSYEDA RESEARCHTerminated
PGR2016-00010Feb 16, 2016MYLAN PHARMACEUTICALSYEDA RESEARCHInstitution Denied
IPR2015-01981Sep 25, 2015AMNEAL PHARMACEUTICALSYEDA RESEARCHFinal Written Decision
IPR2015-01980Sep 25, 2015AMNEAL PHARMACEUTICALSYEDA RESEARCHFinal Written Decision
IPR2015-01976Sep 25, 2015AMNEAL PHARMACEUTICALSYEDA RESEARCHFinal Written Decision
IPR2015-00830Mar 3, 2015MYLAN PHARMACEUTICALSYEDA RESEARCHFinal Written Decision
IPR2015-00644Feb 7, 2015MYLAN PHARMACEUTICALSYEDA RESEARCHFinal Written Decision
IPR2015-00643Feb 6, 2015MYLAN PHARMACEUTICALSYEDA RESEARCHFinal Written Decision

Top competitors of Yeda Research

Top competitors of Yeda Research based on patent oppositions.